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Background: Oocytes and early embryos contain minute amounts of DNA, RNA and proteins, making the study of
early mammalian development highly challenging. The study of the embryo epigenome, in particular the DNA
methylome, has been made accessible thanks to the possibility of amplifying specific sequences according to their
initial methylation status. This paper describes a novel platform dedicated to the genome-wide study of bovine
DNA methylation, including a complete pipeline for data analysis and visualization. The platform allows processing
and integrating of DNA methylome and transcriptome data from the same sample. Procedures were optimized for
genome-wide analysis of 10 ng of DNA (10 bovine blastocysts). Bovine sperm and blastocysts were compared as a
test of platform capability.
Results: The hypermethylation of bovine sperm DNA compared to the embryo genome was confirmed.
Differentially methylated regions were distributed across various classes of bovine sperm genomic feature including
primarily promoter, intronic and exonic regions, non-CpG-island regions (shore, shelf and open-sea) and CpG islands
with low-to-intermediate CpG density. The blastocyst genome bore more methylation marks than sperm DNA only
in CpG islands with high CpG density. Long-terminal-repeat retrotransposons (LTR), LINE and SINE were more methylated
in sperm DNA, as were low-complexity repetitive elements in blastocysts.
Conclusions: This is the first early embryo compatible genome-wide epigenetics platform for bovine. Such platforms
should improve the study of the potential epigenetic risks of assisted reproductive technologies (ART), the establishment
sequence of embryonic cell lines and potential deviations in both gene expression and DNA methylation capable of
having long-term impact.
Keywords: Epigenome, DNA methylation, Bovine embryo, Methylome and transcriptome parallel analysis, Analysis
pipeline, CpG enrichment, Repetitive elements, Epigenome-wide association studyBackground
The study of early embryonic development continues to
pose formidable technical challenges due in large part to
the limited amounts of sample material. However, high-
throughput high-fidelity amplification of nucleic acid is
making the macromolecular study of embryonic physiology
more accessible. Microarray platforms, and more recently
RNAseq, have made studying the early embryo transcrip-
tome almost routine. Our group has been developing* Correspondence: claude.robert@fsaa.ulaval.ca
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article, unless otherwise stated.bovine and porcine microarrays based on transcriptomic
platforms that include standardized sample preparation
procedures and a complete user-friendly software suite for
data normalization and analysis, allowing efficient process-
ing of samples from extraction through to the generation of
publishable graphs [1,2]. Transcriptomic platforms have
been used to study how early embryos of many different
species interact with their immediate microenvironment
[3-8]. Although very useful, the transcriptome has not
allowed us to determine whether or not deviant gene ex-
pression, that is observed in embryos, is a transient adapta-
tion to surrounding conditions that later yields to normal
expression without any long-term impact on development.
In order to provide a more complete picture of embryo
adaptation and its potential long-term consequences, studyentral Ltd. This is an Open Access article distributed under the terms of the
/creativecommons.org/licenses/by/4.0), which permits unrestricted use,
, provided the original work is properly credited. The Creative Commons Public
mons.org/publicdomain/zero/1.0/) applies to the data made available in this
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http://www.biomedcentral.com/1471-2164/15/451of the epigenome is necessary [9,10]. The epigenome is the
sum of all epigenetic information [11] and refers more
precisely to the complete description of chemical changes
to DNA and histones [12], including histone tail modi-
fications, chromatin remodelling proteins, and ncRNA.
Epigenomics and transcriptomics are closely interre-
lated in terms of gene function and regulation [13,14]
and together modulate gene expression.
Among epigenomic effectors, DNA methylation is be-
lieved to be a strong primary molecular mark having a
major impact on intergenerational gene silencing [15,16].
DNA methylation patterns are known to be relatively stable
and established in a tissue-specific manner [17,18]. How-
ever, following fertilization and during mammalian pre-
implantation development, the DNA methylation pattern is
dynamic and undergoes reprogramming in the form of a
wave of genome-wide de-methylation and re-methylation
[19-24], thus putting the embryo at risk of programming
errors [25]. Furthermore, the study of how the DNA
methylome can be modified by changes in the embryo
microenvironment such as in vivo/vitro culture, uterine
conditions, or maternal nutritional regimen has represented
a major challenge and continues to do so, due mainly to
sample scarcity offering input DNA well below minimal
recommendations.
Numerous platforms already exist to study methylation
of targeted loci or to obtain genome-wide methylation pro-
files. For the study of very small samples, determining
DNA methylation at targeted loci has so far been more suc-
cessful than genome-wide approaches [26]. The main ad-
vantages of general survey are the possibility of describing
physiological responses at the genome-wide scale and the
potential for novel discovery.
The aim of the present work was to develop a techno-
logical platform that is complementary to existing plat-
forms, in order to provide a whole-genome view of DNA
methylation in bovine early embryos. Since a diploid mam-
malian nucleus contains about 6.8 picograms of DNA
(www.genomesize.com) and the expanded blastocyst of
large mammalian species is composed of about 150 cells, a
single bovine blastocyst contains approximately 1 ng of
DNA. The current benchmark for minimal sample size is
around 10 ng, therefore corresponding to a pool of 10
expanded blastocysts. The other criterion is ease of use, at
both the sample handling and data processing steps. We
thus sought to identify an existing methodological approach
which would be best suited to analyze very small samples




The EmbryoGENE (http://embryogene.ca) DNA Methylation
Analysis (EDMA) platform was designed for high-throughputmethylation profiling of bovine genome using limited
amounts of input material. It combines four independent
methodological principles: i) restriction endonuclease-
based (RE) (MseI) genomic DNA fragmentation; ii) target-
ing methylated regions using a cocktail of methyl-sensitive
restriction endonucleases; iii) amplification of methylated
(thus protected) fragments using ligation-mediated PCR;
and iv) identification of the amplified methylated fragments
using a microarray. The EDMA workflow is presented in
Figure 1.
Sample treatment protocol and microarray design were
optimized in parallel. Our laboratory has previously con-
ducted a survey of DNA methylation in bovine embryos
using various reduced representation approaches [27]. This
allowed us to identify a collection of loci at which DNA
methylation varies in association with early development.
These loci included CpG islands, gene bodies, intergenic re-
gions and repetitive elements. The oligo design accounted
for the sample preparation steps in which genomic DNA
was fragmented using the MseI restriction enzyme, which
recognizes 5′-T/TAA-3’, thus avoiding methylated cytosine
residues. In silico digestion of the bovine genome shows
that MseI yields fragments averaging 160 bp in length (see
Additional file 1: Figure S1 A). A second layer of in silico
analysis located the methyl-sensitive restriction endonucle-
ases (MSRE) restriction sites, namely C/CGG (HpaII), GC/
GC (HinP1I) and C/CGC (Aci1I). Distribution of common
and unique MSRE sites within MseI fragments is shown in
Additional file 1: Figure S1 B. Furthermore, the information
regarding the number of CpG sites per restriction frag-
ments and the number of MSREs restriction sites per re-
striction fragments are provided in Additional file 1: Figure
S2 A-D. The 60-mer oligo design was based, in part, on a
collection of MseI fragments containing MSRE sites within
the genomic loci that we previously found to bear methyla-
tion or hydroxymethylation marks in early bovine embryos
[27], to which were added CpG islands determined by in
silico analysis. Additional oligos were designed by tiling the
MseI fragments adjacent to this initial set of targets until
the capacity of a single microarray slide was reached (1×1
M oligos). Preliminary hybridizations allowed selection of a
subset of 400 K oligos that performed well, based on se-
quence specificity and signal strength variations across the
set of test hybridizations (data not shown). The final probe
collection queries a variety of different genomic features
not limited to CpG islands. A summary of the genomic tar-
gets surveyed by the microarray is shown in Figure 2 and
Additional file 2: Table S2-4. As illustrated for two bovine
imprinted genes (NNAT, PEG10) in Figure 3, the EDMA
probes were distributed across various genomic features
(intergenic, promoters, gene body, and repetitive elements).
Since the platform uses a cocktail of MSREs to target
genomic locations bearing methylation marks, the extent
of cleavage is a critical factor. Incomplete cleavage will
Figure 1 Sequence of steps involved in the generation of methylome and transcriptome data from the same sample using EDMA
platform. A quality control step prior to LM-PCR allows evaluation of the efficiency of cleavage by MSREs for methylome analysis. EDMA:
EmbryoGENE DNA methylation analysis platform, ELMA: EmbryoGENE LIMS and Microarray Analysis, EMBV3: EmbryoGENE bovine transcriptomics
microarray Version 3, LM-PCR: Ligation-mediated PCR, MSRE: Methyl-sensitive restriction endonuclease, RE: Restriction endonuclease (MseI).
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poses, control DNA templates were designed to account
for extent of cleavage both by MseI and the MSREs
cocktail. A pair of DNA templates was designed for each
MSRE (Figure 4A). All spiked-in controls had internal
MseI sites at their ends, and for each pair, one template
was methylated in vitro for protection against MSRE
activity. The controls were thus subjected to the same
cleavage conditions as the sample. Following genomic frag-
mentation, adaptor ligation and MSRE treatment, sample
quality was determined using qPCR, with calculation of the
extent of cleavage for each MSRE. The difference in thresh-
old cycle (Ct) between protected (hypermethylated) and un-
protected (hypo/unmethylated) control templates can be
calculated, while sample uniformity can be visualized fromthe amplification curves (Figure 4B, 4C). Only samples dis-
playing uniformity with the other samples cleaved > 97% in
the same cohort were retained for downstream treatment.
Insufficiently cleaved samples were in some cases subjected
to a second treatment with additional MSRE digestion.
In EDMA platform, after hybridization on the micro-
array and data analysis there are two types of quality
control (QC) plots which the examples are shown in
Figure 5. The first plot, which assesses the completeness
of the genomic digestion, shows nearly complete cleav-
age by MseI, with most control probes showing signal
below the background noise (Figure 5A). The second
quality control assess the quality of detected signals.
The plot uses signals from probes corresponding to
the spiked-in controls, and confirms that unprotected
Figure 2 The characteristics of EDMA array. (A) Gene region
coverage by the probes. The single greatest proportion (34%)
corresponds to intronic regions. (B) Probe distribution based on
proximity to CpG islands as well as CpG islands-related enrichments.
More than half of the probes target fragments in the open-sea region.
(C) Proportions of different classes of bovine repetitive elements
detectable by the EDMA platform.
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tected fragments (Figure 5B).
The analysis pipeline
For each dye-swaps microarray hybridization, the quantifi-
cation of methylation measurements are based on M values
(the log differential- expression ratio of the two channels)
which further normalized (inter & intra-array) and statis-
tical analysis is performed as described in methods. This
means larger values represented more evidence of relative
methylation similar to other microarray-based genome-wide DNA methylation analysis platforms [28]. To support
data mining, an extensive analysis pipeline was designed
with the goal to sort the data according to defined struc-
tural characteristics (e.g. near known genes, within gene
body components, distance from CpG islands, etc.). We de-
signed a user-friendly and comprehensive bioinformatics
data analysis pipeline to complement our developed plat-
form (EDMA). A complete schematic of our data analysis
pipeline is shown in Figure 6. The data analysis pipeline
was designed to be compatible with results obtaining from
our array-based gene expression platform [1]. It enables to
identify alterations of DNA methylation in bovine genomic
regions under various enrichment outputs in parallel to de-
viations in transcription. The pipeline comprises several
analysis steps for data QC and differential analysis, generat-
ing a list of DMRs as well as downstream sequence-based
enrichment analyses, Hot spot detection and concordant
analysis in search of loci where both transcriptomic and
DNA methylation are affected. The information is binned
according to the set of annotations given to every genomic
locus (see methods for details). Typical enrichment analysis
account for CpG islands neighbourhood both in length and
density, gene body structures (promoter, exons, introns)
and classes of bovine repetitive elements (low complexity,
SINE or LINE elements). Since EDMA is not based on bi-
sulfite conversion and sequencing, it does not provide a
relative value of the extent of DNA methylation. This infor-
mation needs to be determined by targeted pyrosequening
of the regions of interest.
The data analysis pipeline output is a large contingent
of plots that serve five different objectives (Figure 7): i)
to document the quality of the samples through the
quality control plots ; ii) to provide visual aid to deter-
mine where the MSRE-protected fragments were found
for each sample type; iii) to provide an overall perspec-
tive of the extent of the differences in methylation be-
tween the samples; iv) to mine differentially methylated
regions (DMRs) data according to genomic features; v)
and lastly, the Circos plot which can be used to integrate
the epigenomic and transcriptomic data (or present a
chromosomal overview of either type alone).
DNA methylation profiles of bovine sperm and early
embryos
– Genome-wide overview of DNA methylation
profiles.
Platform performance was evaluated on the basis of the
contrast in genomic DNA methylation patterns between
bovine sperm and blastocysts. Similar amounts of input
DNA from both sample types were processed, and micro-
array data was analyzed using the pipeline described
above. Using a predetermined significance criterion i.e.
Figure 3 Snapshots from the UCSC genomic web-browser describing the genomic locations of two bovine imprinted genes (NNAT
and PEG10), positioning of the probes (methylome and transcriptome) and other associated bovine genomic features. MseI recognition
sites on genomic DNA result in MseI-MseI fragments. CpG islands may be absent (Area A) or present (Areas B-D). EDMA probes may target CTCF
binding sites (blue arrows), which may be proximal (Area A) or within (Area C) the gene body. Other EDMA probes (red arrows) also may overlap
with probes the transcriptomic (EMBV3) array or cover CpG islands or non-CpG islands. Probes (red arrows) may also cover intronic or exonic
portions of the genome (Area D).
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tified, most of which (>85%) were due to hypermethyla-
tion in sperm (Figure 8). Large numbers of the methylated
loci found in the embryo genome were also found in
sperm DNA. Differences can also be observed using the
genome-wide view provided by Circos plot, which shows a
prevalence of hypomethylation in the sperm for chromo-
some X compared to blastocysts DNA. Nearly all (97%) of
the top 100 identified differentially methylated regions
(DMRs) were found to be hypermethylated in sperm
DNA (Figure 9). This reveals that the majority of DMR
genes in bovine sperm DNA lose their methylation after
fertilization and during early embryo development, at least
until the blastocyst stage.
– Characteristics of differentially methylated regions
(DMRs).
Our data revealed that sperm DNA shows a tendency
to hypermethylation compared to blastocysts in all types
of promoter, intronic and exonic regions, non-CpG
islands regions (shore, shelf and open sea) and CpGislands with low-to-intermediate CpG density and small-
to-intermediate length (Figure 10). Only in high-density
CpG islands in the blastocyst genome demonstrated a ten-
dency to hypermethylation compared to sperm. Amongst
DMRs containing repetitive elements, bovine sperm DNA
tended to be hypermethylated in the majority of the
repetitive element classes, in particular long-terminal-repeat
(LTR) retrotransposons, LINE and SINE. However, low-
complexity repetitive elements showed more hypermethy-
lated in the blastocyst genome.
DMR validation
Seven candidate DMR loci from different regions of the
bovine genome were selected and primers were designed
(see Additional file 2: Table S5) for measurement of
DNA methylation levels by pyrosequencing. These re-
sults confirmed those obtained using our platform and
showed very high levels of methylation with high repro-
ducibility in sperm DNA compared to the blastocyst
genome (Figure 11). However, as expected there was not
any linear correlation between the EDMA fold changes
for the selected DMRs and their corresponding measured
Figure 4 The feature of EDMA spiked-in controls and the quality control process of MSREs digestion assessment. (A) Location of sites
cleaved by endonucleases within exogeous control DNA. (B) Difference in PCR threshold cycle (ΔΔCt) between un-cleaved (positive control) and
cleaved samples. (C) Plot of residual number of copies and corresponding efficiency of cleavage by MSRE versus PCR cycle number, indicating
that satisfactory cleavage (97%) is reached at the end of five PCR cycles.
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Additional file 1: Figure S3).
Discussion
Development of EDMA
The study of the epigenome has become a prime focus in
the effort to understand the expression of complex pheno-
types such as obesity, diabetes [29,30], mental disorders[31,32] and cancers [33-36]. Vast epigenetic erasure and
reprogramming events during early embryogenesis make
this phase of development a window for perturbations, po-
tentially having long-term impact on phenotype in adult-
hood. Methods for monitoring candidate loci using as little
as single cell [37], one oocyte [38] or single cell blastomere
[39] have been developed. The aim of the present work
is to develop a robust technological platform to study
A B
Figure 5 The two types of quality control (QC) plots generating after EDMA microarray hybridization and data analysis. (A) Signal
intensity of control probes designed to overlap an MseI site. Probes corresponded to loci distributed throughout the bovine genome. The dashed
horizontal line represents the limit of detection (mean intensity of negative controls plus four standard deviations). Intensities below this line
indicate successful genomic fragmentation by MseI. (B) Cleavage of synthetic spiked-in control DNA pairs by MSRE, based on microarray signal.
Signals from unprotected (unmethylated) fragments (right) are near background values.
Figure 6 The EDMA DNA methylation analysis pipeline. This genome-wide methylome analysis pipeline was designed to provide a comprehensive
set of plots to ease interpretation of both methylome and transcriptome raw data generated from the same sample. Information is binned according to
known functions or genetic features.
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Figure 7 List of the graphs generated by EDMA analytical pipeline.
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amount of sample material obtainable from early embryos
and to complement this platform with a comprehensive
suite of tools for quality control and data analysis. The
EmbryoGENE DNA methylation analysis (EDMA) platform
was developed for compatibility with our previously pub-
lished transcriptome analysis platform [1] with the aim of
integrating data of both types from the same sample.
Among the three sample treatment options currently
employed to study genomic DNA methylation [26], we
opted for methyl-sensitive restriction enzymes (MSREs)
over bisulfite conversion and affinity selection because it
allowed for robust processing of DNA input of a few
nanograms as well as a more straightforward data pro-
cessing based on the well-established tools dedicated
to microarray data analysis. An optimal procedure was
sought for isolating intact genomic DNA for subsequent
specific fragmentation by nucleases, which offers betterrepeatability than mechanical shearing (data not shown).
The selection of methylated fragments thus obtained is
performed by means of successive PCR reactions, while
amplicon identification is achieved using a microarray,
which brings the added benefit of mature data process-
ing and analysis procedures. In addition, each microarray
slide is composed of two arrays that hold two samples
each (two-color arrays), allowing for the necessary inclu-
sion of biological replicates in the experimental design.
All platforms must include biological replication, since
the extent of DNA methylation is naturally variable
among samples of similar origin.
The procedures involved in EDMA, namely restriction
endonuclease genomic fragmentation, adaptor ligation,
cleavage by MSREs, selection of protected fragments by
PCR and identification of fragments by microarray, are
essentially those proposed for nanoHELP and for array-
comparative genomic hybridization, which have been
Figure 8 Volcano plot of genome-wide DNA methylation. This plot shows clearly that bovine sperm DNA was more methylated than embryo DNA.
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a single cell [40]. Ten nanograms is the approximate
quantity of DNA obtainable from 10 expanded blasto-
cysts. Comparing 1 μg and 10 ng genomic DNA input,
Oda and colleagues demonstrated that the smaller input
provided higher reproducibility (R > 0.96), due probably
to more complete cleavage, suggesting that low input of
genomic DNA would likely be more suitable for MSRE-
based platforms [41]. Sample processing used in EDMA
was tested with lower gDNA inputs as low as 15 cells
and genomic coverage was measured using the 50 K bo-
vine SNP Chip which showed important loss of informa-
tion due to allele drop-out when input were lower than
1 ng (data not shown). When dealing with single cell
DNA methylation analysis, partial sample loss is often
observed. This loss may not be problematic when aiming
for targeted loci but is definitely problematic for genome-
wide profiling. As such, 10 ng was set the minimal input
leading to a robust DNA methylation profiling.
In order to prevent the introduction of false positives that
would arise from incomplete cleavage of sample DNA
[42,43], spiked-in controls were designed to account for ex-
tent of cleavage both during the initial MseI fragmentation
and by MSREs. Samples were tested before fragment ampli-
fication by PCR to ensure that cleavage was sufficient.
When cleavage is incomplete, the MSREs treatment can berepeated. For each MSRE, a pair of synthetic DNA controls
was designed, one of which was methylated in vitro and
used as a control for fragment protection, while the unpro-
tected counterpart acted as the cleavage target.
One of the main concerns with any genome-wide ap-
proach is the actual genomic coverage. Since the MseI
recognition site is T/TAA, CpG dinucleotides are left
intact and most CpG islands are conserved [44]. These sites
are very abundant throughout the genome, resulting in
small fragments well suited for LM-PCR [40,45,46]. By frag-
menting the entire genome in this manner, methylation
status outside CpG islands can be queried. This provides
valuable information, since evidence is mounting for
potential important roles for 5mC in non-CpG islands,
which have been found more dynamic than CpG islands
with respect to methylation-based regulation [47]. This is
potentially even more important in early embryos where
overall demethylation just occurred.
Since detection based on restriction enzymes is limited
to fragments bearing the recognition sites [11,48], ad-
equate genomic coverage by MSRE requires a combin-
ation of nucleases [27,44]. In silico analysis showed that
compared to HpaII alone, the combination of HpaII,
HinP1I and Aci1I increased the coverage of CpGs sites
in the probes designed for EDMA from 2.3% to 8.6%
and genomic coverage from 4.8% to 6.1% (see Additional
Figure 9 The Circos plot showing the genome-wide DNA methylation profile of bovine sperm DNA and the blastocyst genome, by
chromosome. The mean p-values of 5 M bp windows are displayed along with the 100 most significant DMRs. Positive fold-changes represent
hypermethylation in sperm while negative fold-changes represent hypermethylation in blastocysts. The inner circle depicts probe mean values
across treatments to show the completeness of the coverage generated from the microarray signals.
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than 2.3 M CpG sites, which corresponds to about 10%
of all CpG sites in the bovine genome. Similar coverage
is obtained using reduced-representation bisulfite sequen-
cing (RRBS), which has been shown to be efficient with
small DNA input [19,49,50]. Both EDMA and RRBS have
several steps in common, including genomic fragmentation
by restriction enzyme, adaptor ligation and PCR amplifica-
tion. The main benefits of reduced-representation bisulfitesequencing are that it allows quantitative evaluation of
methylation at single-base resolution and is applicable to all
species since it is based on DNA sequencing, which does
not require a priori knowledge of the genome [51]. How-
ever, EDMA similar to any other MSREs enrichment-based
approaches generate a list of DMRs ranked in order of sig-
nificance but does not provide information regarding the
extent of DNA methylation which must be determined by
targeted pyrosequencing. Furthermore, enrichment-based
Figure 10 The comparative analysis of differentially methylated
regions (DMRs) enrichments between bovine sperm and
blastocysts. This figure shows the log2 enrichment ratios between
the numbers of the DMRs found to be hypermethylated in bovine
sperm compared to the number of DMRs found to be hypermethylated
in bovine blastocysts, broken down by different types of genomic
features. The majority of the DMRs showed hypermethylation in bovine
sperm DNA.
Shojaei Saadi et al. BMC Genomics 2014, 15:451 Page 11 of 18
http://www.biomedcentral.com/1471-2164/15/451approaches using antibody or methyl-binding proteins have
not been thoroughly tested with samples containing only a
few ng of DNA. With larger DNA input, these methods
have been shown to provide moderate resolution, since the
capture depends on fragment methylation density [11,52].
While epigenome-wide association studies and the
development of technological platforms suitable forlow input DNA are broadening in scope, improvement
to the standardization of experimental assays across
samples and to data analysis and interpretation re-
mains slow [53]. Although amplicons obtained by
LM-PCR could be processed into sequencing libraries,
we opted for microarray-based identification, which is
more restrictive (being limited to the probes printed
on the array) but has the major benefit of compatibility
with an established, robust and user-friendly data ana-
lysis pipeline. These features may limit genomic cover-
age but definitely increase sample turnover rate by
decreasing the time required to interpret data.
In comparison to gene expression, which is most often
limited to the study of protein encoded transcribed
elements which account for little more than 1% of the
eukaryote genome, profiling overall DNA methylation con-
siders a vastly more complex diversity of sequences, which
in turn complicate data analysis. We therefore sought to
support data interpretation by binning the information ac-
cording to genomic features. Such an approach increases
the statistical power to identify subtle alterations in genome
regions by avoiding P value dilution, through multiple-
testing corrections that include the vast majority of regions
considered a priori unlikely to be differentially methylated
[54]. The data analysis pipeline built in to our platform ac-
counts for: i) site specificity (e.g. promoter, intron, and
exon), ii) region (e.g. shore, shelf, open-sea) and iii) se-
quence composition (e.g. CpG island density and length).
This is in accordance with recent recommendations for
epigenome-wide association studies [53].
The enrichment categorization implemented in the data
analysis pipeline is based on previous studies [49,55-60]
and provides a full complement of graphic outputs. Even
though the graphs might not all be relevant to all users, de-
pending on the experimental design and biological hypoth-
esis, are all produced automatically at no additional cost in
time or resources on the part of the user. Overall, EDMA
was developed as a cost-effective standardized platform that
robustly profiles DNA methylation across the entire bovine
genome. This sample processing platform is also comple-
mented with bioinformatics supports for data analysis with
the specific aim to aid data interpretation.
The importance of genome-scale parallel analysis of the
DNA methylome and transcriptome
Current technological advances and the exponential growth
of epigenetics studies in the past few years, in particular
genome-wide studies, are advancing our knowledge and
providing more evidence for the interdependence of epi-
genetic and genetic variations [53]. By providing genome-
wide parallel survey of the DNA methylome and the
transcriptome for the same sample, EDMA offers a
powerful tool for revealing highly relevant targets and
potential associations between the DNA methylome
Figure 11 Validation of the selected DMRs by pyrosequencing.
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lomic and transcriptomic data has been shown to pro-
vide complementary information [60].
Genome-wide profiles of bovine sperm and blastocyst
DNA methylomes
As proof of concept, we compared the DNA methylation
profiles of bovine sperm and blastocysts and performed
validation by pyrosequencing on selected DMRs. All se-
lected candidates were found to be substantially more
highly methylated in sperm DNA, corroborating the
results obtained with EDMA. Physiologically relevant
data were also generated and compared to the current
literature. The sperm genome was found hyper-methylated
compared to the embryo, which is consistent with the de-
methylation process known to occur after fertilization in
bovine [61] and other species such as mouse [49,50]
and zebra fish [62]. The data also indicated that large
numbers of loci methylated in bovine embryos are also
methylated in sperm DNA, which also corroborates a
previous report [62]. As previously observed in mice
[50], we found that from the DMRs enrichment, that
short length/low density CpG islands showed a higher
tendency to changes (i.e. being a DMR) than other re-
gions. The direction of change is predominantly to-
ward hypermethylation in sperm, but not always. Inaddition, we observed a high level of methylation in
many repetitive elements, which is also in agreement
with the patterns observed in mice [49,50].
We observed marked differences (more hypermethy-
lated DMRs in sperm) in the extent of methylation in
long-terminal-repeat (LTR) retrotransposon, similar to
previous findings with mice [50]. Furthermore, it has
been shown that the sperm contributed DMRs in pre-
implantation embryos at LTRs were associated with
reduction of DNA methylation and the most drastic
methylation changes (reduction) in the sperm-to-zygote
transition observed in some families of LINE and LTR
retrotransposon [49]. In our previous report, we also ob-
served a transition in DNA methylation in LTR during
bovine embryo development from Day 7 to Day 12 [27].
The reason for the observed large difference in LTR
methylation during early development and, as shown
specifically in this study, between sperm and blastocysts
is not yet clear, although these differences might reflect
the importance of de novo establishment of genome-
wide methylation in the bovine early embryo. In this re-
gard, robust LTR retrotransposon up-regulation has been
shown during activation of the bovine embryo genome
[63] and found to be a general requirement for progres-
sion through to the cleavage stage in mouse embryos
[64,65]. However, the nature of its role in mammalian
Shojaei Saadi et al. BMC Genomics 2014, 15:451 Page 13 of 18
http://www.biomedcentral.com/1471-2164/15/451early development remains elusive. Furthermore, it has
been suggested that LTR re-methylation occurs in the
early, rather than late, pre-implantation mouse embryo
[64]. Furthermore, the observation that a higher number
of DMRs are present in low-complexity simple repeats in
bovine blastocysts, in comparison with sperm, might rep-
resent notable dynamic changes in 5 mC in these specific
class of repetitive elements during bovine early embryo
development and differentiation [66].
Conclusion
By developing EDMA, we are providing a unified and re-
liable approach to analyze small amounts of genomic
DNA, one that offers a good balance between genomic
coverage and data turnaround time. The use of a micro-
array for fragment identification is robust, efficiently
minimizing sample-to-data time. The built-in data ana-
lysis pipeline provides efficient means for data interpret-
ation. The integrated data analysis pipeline could be a
good option for researchers with limited bioinformatics
resources. The platform is at the present time specific
for the bovine genome, but a similar approach could be
adapted easily to any species of which the entire genome
is known. Such platforms enable the study of the poten-
tial epigenetic risks associated with assisted reproductive
technologies (ART) or to highlight the sequence of




Experiments took place in compliance with the guidelines
of the Canadian Council on Animal Care and supervised by
the Animal Protection Committee of Université Laval.
These guidelines are strictly followed by the local abattoir
and L’Alliance Boviteq who provided all the tissues and
samples. The study did not require handling animals on
university premises.
Microarray design
The design of the EmbryoGENE (http://embryogene.ca)
DNA Methylation Array (EDMA) was based on a compil-
ation of methylation-sensitive genetic loci found previously
to be involved in early embryonic development [27]. To
maximize genomic coverage, all probes on the EDMA array
were designed on the assumption that genomic cleaving
using the MseI (T/TAA) restriction endonuclease would be
nearly complete. All probes therefore targeted a specific
MseI-MseI fragment within the bovine genome. Target loci
were selected on the basis of their proximity to either the
putative sites identified in our previous study [27] or to
known CpG islands. Tiling of fragments neighboring the
selected loci was then carried out until enough loci were se-
lected to fill one Agilent SurePrint 1×1M slide (AgilentTechnologies). Test hybridizations were carried out, and
the best-performing 400,000 probes were selected for place-
ment on the final Agilent SurePrint 2×400K array. Probe
quality was measured by assessing sequence specificity and
signal strength variation across the set of test hybridiza-
tions. The final EDMA array (EDMA.V2) contains 414,566
probes targeting 359,738 loci, surveying 20,355 genes and
34,379 CpG islands. The microarray also contains 10,388
control probes accounting for 2.5% of all the total probes,
representing 5,610 Agilent proprietary spiked-in controls,
4,634 genomic cleavage controls and 144 EDMA spiked-in
methylation controls. Controls were designed with an MseI
restriction site at their center and were tiled at every 1 M
base pairs throughout the bovine genome. These were used
to assess the degree of genomic digestion. The EDMA
spiked-in controls are exogenous DNA fragments
(Solanum lycopersicum) chosen for their lack of hom-
ology with the bovine genome and for the presence of
specific HpaII, AciI and HinP1I restriction sites within
their sequence. They were artificially methylated or
left unmethylated to provide positive and negative con-
trols for the methylation-sensitive cleavage. Probe design
for the EDMA microarray was carried out by Genotypic
Inc. (Bangalore, India). The arrays were printed using the
SurePrint technology (Agilent Technologies). The details
of the EDMA platform array have been deposited in
NCBI’s Gene Expression Omnibus (GEO) (http://www.
ncbi.nlm.nih.gov/geo/) and are accessible through GEO,
Platform accession number: GPL18384.Sample production and genomic DNA extraction
Bovine blastocyst production in synthetic oviduct fluid
(SOF) media was performed as described previously
[27]. The ovaries were collected at a local abattoir which
is complying with the guidelines provided by the Canadian
Council on Animal Care. Only expanded-blastocyst-stage
embryos were collected, in four pools of ten embryos
(n = 40). All embryos were washed three times with
RNAse-free phosphate-buffered saline (PBS) prior to
snap-freezing and storage at −80°C. Extraction of genomic
DNA was carried out using an AllPrep DNA/RNA Mini
Kit (QIAGEN, Mississauga, ON, Canada), and samples
were eluted in 30 μL. Straws containing frozen semen
from Holstein bulls were obtained from L’Alliance Boviteq
Inc (Saint-Hyacinthe, QC, Canada). L’Alliance Boviteq Inc
is a commercial service provider also complying with the
guidelines provided by the Canadian Council on Animal
Care. Sperm genomic DNA was extracted using lysis buf-
fer, followed by ethanol precipitation. The quality and
quantity of extracted DNA were analyzed by optical ab-
sorbance using a Nanodrop ND-1000 spectrophotometer
(NanoDrop Technologies Inc.) and by electrophoresis on
0.5% agarose gel at 45 volts for 2 h.
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The same DNA input (10 ng) was used for both embryo
and sperm samples. For quality control purposes, all
samples were spiked in with a mixture of six synthetic
DNA constructs harbouring MseI restriction sites at
each end. One pair of constructs was designed for each
methyl-sensitive restriction enzyme (HpaII, HinP1I and
Aci1I) to be used in the fragment selection process. For
each pair, one control DNA fragment was methylated
in vitro using CpG methyltransferase M.SssI (New
England Biolabs). The difference between the extents of
cleavage obtained with each pair was used to calculate
cleavage efficiency. Residual MseI sites within the frag-
ments were measured after processing to determine the
extent of genomic fragmentation.
Sample (in 30 μL of elution buffer) plus 0.5 μL of bo-
vine serum albumin (New England Biolabs), 5 μL of 10×
Buffer 4 (New England Biolabs) and 28 μL of DNAse/
RNAse free water were divided into two equal fractions
and fragmented using 10 U of MseI (New England
Biolabs) as follows, 16 h at 37°C followed by 65°C for
20 min. The two fractions were combined and DNA
was concentrated by ethanol precipitation following
addition of 5 μg of linear acrylamide solution (Ambion)
as carrier and 5 μL of sodium acetate buffer (3 M,
pH 5.5, Ambion Inc.). The pellet was washed twice
with 70% ethanol, air-dried and resuspended in 5 μL of
DNAse/RNAse free water.
Fragmented genome DNA adapter ligation Adaptors
were ligated to the MseI digested genomic fragments as
described previously [40]. Briefly, 5 μM of each primer
(MseLig 21: 5′-AGT GGG ATT CCG CAT GCT AGT-
3′, MseLig 12: 5′-TAA CTA GCA TGC-3′, IDT DNA),
0.5× One-Phor-All plus Buffer (Pharmacia Biotech) and
1.5 μL of nuclease-free water were added to the sample.
Annealing was initiated at 65°C for 1 min, and the
temperature was ramped at 1°C/min down to 15°C. T4
DNA ligase (5 units, Boehringer Mannheim) and 10 nmol
of ATP were added and the reaction and incubated for
16 h at 15°C.
HpaII tiny fragment enrichment by ligation-mediated
PCR (HELP) cocktail cleavage of ligated genomic
DNA The ligated sample was triple-cleaved with FastDigest™
methyl-sensitive restriction endonucleases (MSRE) HpaII
(C/CGG), HinP1I (GC/GC), Aci1I (C/CGC) (Fermentas
Thermo Fisher Scientific) using a sequential digestion.
Samples were first digested in 50 μL reactions that in-
cluded 10 μL of sample, 0.5 μL of HpaII, 0.5 μL of HinP1I,
5 μL of 10× FastDigest buffer and 34 μL of nuclease-free
water for 12 h at 37°C. A second cleavage was performed
by adding 0.5 μL of Aci1I, 5 μL of 10× FastDigest buffer
and 44.5 μL of nuclease-free water and incubating at 37°Cfor 4 h, followed by thermal inactivation at 85°C for
10 min.
Verification of cleavage: qPCR of spiked-in templates
The extent of cleavage by MSREs was determined
using qPCR detection of spiked-in controls. A master
mixture (19 μL) containing 2 mM MgCl2, 1× LightCycler
FastStart DNA Master SYBR Green mix (Roche Diagnostics
Canada, Laval, QC, Canada), 14.4 μL of nuclease-free
water and 1 μL of cleaved sample (template) was divided
into three fractions to which 0.25 μM of each forward and
reverse primer designed to target the appropriate control
template was added (see Additional file 2: Table S1). Each
qPCR run also included a positive control (non-digested
spiked-in, 1/1000 dilution) and negative control (no tem-
plate). The qPCR conditions were as follows: initial de-
naturation was carried out at 95°C for 10 minutes,
followed by 50 amplification cycles at 95°C for 5 seconds,
52°C for 5 seconds and 72°C for 20 seconds. Melting curve
analysis was performed for 1 cycle with a ramp rate of
0.2°C per second, starting at 94°C for 5 seconds, 72°C for
30 seconds, and back to 94°C for 0 seconds, and cooling
at 40°C.
Amplicon specificity was determined from the shape
of the melting curve and the difference in cycle thresh-
old (Δ Ct) between methylated (MSRE cleavage pro-
tected) and unmethylated (MSRE cleavage unprotected)
templates was used to calculate cleavage efficiency. The
DNA samples were then precipitated by ethanol, washed
and dissolved in 10 μL of nuclease-free water.
Fragment selection by ligation-mediated PCR Select-
ive amplification of methylated fragments was performed
using two rounds of ligation-mediated PCR (LM-PCR)
as described previously [40], with some modifications.
The first LM-PCR amplification was carried out in
50 μL using 10 μL of sample to which 1 μM of primers
(MseLig12 and MseLig21) was added, 0.1× One-Phor-All
plus Buffer (Pharmacia Biotech), 0.6× Ex Taq™ buffer with-
out Mg2+ (TaKaRa), 0.1 U Ex Taq™ enzyme (TaKaRa),
1.5 mM MgCl2 , 0.4 mM dNTP , and 23.5 μL of nuclease-
free water. The mixture was then subjected to thermal cyc-
ling as follows: 94°C (40 sec), 57°C (30 sec) and 72°C (1 min
15 sec) for 15 cycles; 94°C (40 sec), 57°C (30 sec) and 72°C
(1 min, 45 sec) for 34 cycles; and 94°C (40 sec), 57°C
(30 sec) and 72°C (5 min) for the final cycle. The PCR prod-
ucts were resolved on 1% agarose gel to assess the quality.
To obtain sufficient DNA for downstream processing,
three PCR reactions were carried out using 0.75 μL aliquots
from the first LM PCR, to which 1.5 μM MseLig21 primer
was added, plus 1× Buffer 1 (Roche/Boehringer Mannheim,
Expand Long Template), 0.2 mM dNTPs, 0.8 μL of
Expand Long Template Enzyme Mix (Roche/Boehringer
Mannheim) and 38.7 μL of nuclease-free water. The
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65°C (30 sec), and 72°C (2 min) for 1 cycle; 94°C (40 sec),
65°C (30 sec) and 72°C (90 sec) for14 cycles; 94°C (40 sec),
65°C (30 sec) and 72°C (2 min) for 9 cycles and 72°C
(5 min) as the final cycle. The quality and concentration of
DNA were evaluated as described above.Adaptor removal The amplified product from the second
LM-PCR was purified using a QIAquick PCR Purification
Kit (Qiagen) according to the manufacturer’s instructions
with minor modifications. Final elution volume was
41.5 μL, of which 1.5 μL was used for quantification by ab-
sorbance measurement. The rest was divided in two sep-
arate 20 μL aliquots. Adaptors were removed by digestion
for 16 h at 37°C with 1 U of MseI (New England Biolabs).
The mixture also contained 1× bovine serum albumin
(New England Biolabs, Ipswich, MA, USA), 1 × Buffer 4
(New England Biolabs), and 24 μL of nuclease-free water.
The reaction was terminating by heating for 20 min at
65°C. The sample was then purified using a QIAquick
PCR Purification Kit (Qiagen), eluted in 23.5 μL of
nuclease-free water and quantified by absorbance.Sample labeling and hybridization For each sample,
2.5 μg of DNA was labeled using the Universal Linkage
System (ULS) labeling kit (Kreatech Biotechnology) ac-
cording to the manufacturer’s instructions with minor
modifications: 1 μL of Cy-ULS dye was added per 1 μg
of genomic DNA adjusted with 10× labeling buffer. The
labelling mixture was then held for 30 min at 85°C in a
thermocycler, followed by 3 min on ice. Non-reacted
ULS-Cy3/5 was removed by purification using a QIAquick
PCR Purification Kit and samples were eluted in 23.5 μL
nuclease-free water. A 1.5 μL aliquot was used to determine
DNA concentration and dye incorporation using the ND-
1000 NanoDrop. Hybridizations were performed according
to the microarray manufacturer’s instructions (Agilent
Technologies). Briefly, 1 μg of labeled sample (in 40 μL)
was mixed with 158 μL of hybridization master mix con-
taining 25 μL of bovine Cot-1 DNA (1.0 mg/mL, Bovine
Hybloc competitor DNA, Applied Genetics Laboratories),
2.6 μL of Agilent 100x Blocking Agent and 130 μL of
Agilent 2× HI-RPM Hybridization Buffer (Agilent
Technologies). Samples were held at 95°C for 3 min
and at 37°C for 30 min followed by addition of 65 μL of
Agilent-CGHBlock (final volume 260 μL). The samples
were loaded onto the microarray and hybridization was
carried out in a hybridization oven (Shel Lab) for 40 h
at 65°C and 20 rpm. Washing was carried out according
to the microarray manufacturer’s instructions and slides
were scanned with the PowerScanner (Tecan) and analyzed
with Array-Pro Analyzer 6.3 software (MediaCybernetics).Bioinformatics
Data analysis pipeline To complement our transcrip-
tomic platform [1], a complete suite of data analysis
tools was added and integrated into the EmbryoGENE
LIMS and Microarray Analysis (ELMA) gateway (http://
elma.embryogene.ca/). This pipeline processes sample-
associated information, experimental design and proto-
cols, as well as microarray data analysis for identification
of differential gene/loci lists and further data mining for
enrichment analyses. EDMA data was analyzed using
the Limma package from Bioconductor [67,68]. First,
Loess intra-array normalization followed by quantile
inter-array scale normalization were applied. Normalized
data was then fitted to a linear model and Bayesian
statistics of differential expression were obtained. Differ-
ences in DNA methylation were considered significant
when the P value was < 0.05 and the absolute log2 fold-
change was at least 1.5. The inter-treatment compari-
sons were conducted using between-group analysis
based on Eigen values using the Bioconductor package
MADE4 [69]. Visualization tools were developed to gen-
erate plots of the extent of cleavage of spiked-in controls
and overall genomic cleavage for quality control purposes.
Different plots including Volcano plots were generated to
visualize the amount of differentially methylated regions
among treatments. Normalized data and a list of differen-
tially methylated loci can be exported as text files for down-
stream data mining. Different enrichment analyses for
genome-scale DNA methylation data are performed
through a string of integrated scripts that categorize the
information based on CpG island density [49], CpG island
length [57], CpG island distance [58], genomic location
and types of repetitive elements [70]. The pipeline also
pinpoints methylation hot spots, generates bedgraph files
appropriate for visualization within a genome browser,
and uses Circos plot [71] to generate a circular graph
representing overall methylation levels and correlating
these to transcription levels, if the latter data are available.Parameters definitions The CpG island lengths, density
and positions for the UMD3.1 (ftp://ftp.cbcb.umd.edu/
pub/data/assembly/Bos_taurus/) build of the bovine
genome was obtained from the UCSC genome browser
[72]. For any given gene in EDMA, there are five types
of annotation “windows” including; 1) Distal promoter,
2) Promoter, 3) Proximal Promoter, 4) Exons and 5)
Introns. The “Proximal Promoter”, “Promoter” and
“Distal Promoter” regions are defined as the first 1
kbp, 5 kbp and 50 kbp 5′ of the transcription start site
(TSS). For each probes, genes are added to the appro-
priate columns if their MseI-MseI fragment overlap
those windows. Genomic locations which were not
Shojaei Saadi et al. BMC Genomics 2014, 15:451 Page 16 of 18
http://www.biomedcentral.com/1471-2164/15/451part of a CpG island were further split into three types
based on their distance from the nearest CpG island:
“CpG shores” for regions within 2,000 nucleotides of
an island, “CpG shelves” for regions between 2,000 and
4,000 nucleotides of an island and “Open Sea” for re-
gions further away [58]. Probes whose fragment over-
laps a CpG island were annotated using the descriptive
characteristics of that island. Of all CpG island sur-
veyed by the array, those in the bottom 20 percentile of
length were classified as “short”, those at the top 80
percentile were classified as “long” and all others were
classified as “intermediate” [57]. The same scheme was
applied to CpG island density, with the bottom 20 per-
centile being labelled “low density”, the top 80 percent-
ile being labelled “high density”, and all others being
labelled “Intermediate density” [49]. Bovine repetitive
elements content were identified by RepeatMasker
(http://www.repeatmasker.org/) with build 20120418 of
the RepBase database [70] and then used the repeat
classes attribute (LINE, SINE, etc.) as a basis for cat-
egory enrichment. The “methylation hot spots” is calcu-
lated as the averages p-values of differential methylation
over windows of 100 K nucleotides. More specifically,
for all probes on the array, we look up all other probes
within 100 K nucleotides upstream and downstream,
and average the p-values thus obtained. The averaged p-
values have no statistical meaning, but can be used as
an indicator for regions of interest, which we called a
“methylation hot spot”.
Data validation
Pyrosequencing was performed as described previously
[73]. Briefly, blastocyst and sperm DNA samples were
bisulfite-converted using an EZ DNA methylation direct
KIT, (ZYMO Research) followed by amplification of target
loci by PCR prior to sequencing. For all pyrosequencing
assays, PyroMark Assay Design software (Qiagen) was
used to design three oligonucleotide primers (forward, re-
verse and sequencing), synthesized by Integrated DNA
technologies (Coralville). All reverse primers were bio-
tinylated at the 5′ terminus and purified by HPLC. PCR
amplification was carried out in 25 μL containing 0.2 μM
of each forward and reverse 5′-biotinylated primer, 1.25 U
of Platinum Taq DNA polymerase (Invitrogen), 1× Taq
DNA polymerase buffer, 0.2 mM dNTPs, 3–4 mM MgCl2,
2 μL of bisulfite-treated DNA and 17.5 μL of nuclease-free
water. The following three-step program was used: 95°C
(5 min) for 1 cycle, 95°C (30 sec), 48°C for DMR1b, 49°C
for DMRs 2 and 3a, 50°C for DMRs 1a, 3b, 5–8 and 54°C
for DMR 4 (30 sec) and 72°C (30 sec) for 35 cycles, and fi-
nally 72°C (5 min). The specificity of the amplification was
verified by electrophoresis on 2% w/v agarose gel at 90 V
for 45 min. Templates were purified by adding 2 μL of
streptavidin-coated Sepharose beads (GE Healthcare) inthe presence of 40 μL of binding buffer (Qiagen) and then
pyrosequenced [74]. Pyrosequencing reactions were con-
ducted using a PyroMark Q24 apparatus (Qiagen).
Availability of supporting data
The data analysis pipeline user manual is available at;
[EDMA user manual]: http://emb-bioinfo.fsaa.ulaval.ca/
bioinfo/html/epigenetics/Epigenetics%20Analysis%
20Pipeline.pdf.
The dataset of microarray results have been depos-
ited in NCBI’s Gene Expression Omnibus (GEO) and




Additional file 1: Figure S1. (A) This histogram shows the in silico
analysis of the lengths of MseI/MseI fragments across the bovine genome.
Higher frequencies of shorter fragments with an average size <160 bp
are observed. (B) The Venn diagram shows the overlaps between
restriction sites of the HELP cocktail MSREs within the genomic MseI
fragments targeted by EDMA probes. Figure S2. This figure shows the
histogram number of (A) CpG dinucleotide per MseI restriction fragments
and histograms number of MSREs ((B) HpaII; (C) HinP1I; (D) AciI) restriction
sites per restriction fragments in EDMA. Figure S3. This figure clearly
shows that there is not any correlation between the determined EDMA
fold change and Pyrosequening results due to the enrichment-based
nature of the applied protocol.
Additional file 2: Table S1. The designed Primers for the MSRE
digestion quality control step. Table S2. Genomic and CpG coverage by
MseI fragments targeted by EDMA probes as a function of the MSRE sites
present within those fragments. Table S3. Gene and CpG Island
coverage by EDMA probes. Table S4. Breakdown of the location of
EDMA probes in relation to annotated features of the bovine genome.
Table S5. The properties of the selected hypermethylated DMRs and
their primers designed used for pyrosequencying.
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